Revalesio, a clinical-stage pharmaceutical company developing treatments for acute and chronic neurological disorders, today announced data from a post hoc analysis of its completed Phase 2 RESCUE ...

The gut microbiota affects the delicate balance of the intestinal tract as well as brain health. Researchers are hot on the ...

Prominently featured in The Inner Circle, Amor R. Mehta, MD is acknowledged as a Pinnacle Lifetime Member for his contributions to Advancing Neurology and Epilepsy Care. Dr. Amor R. Mehta, a ...

Billy Joel has announced he's canceling upcoming concerts due to health issues following a series of frail performances that ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...

Most awareness campaigns ask for your attention. This one is screaming for you to ignore it. To mark Tourette’s Awareness ...

Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - ...

Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type ...

Data highlights advantages of single, non-replicative HSV-1 (nrHSV-1) vector hosting two transgenes with independent expression kineticsVectors also show high transduction rate of neurons in the CNS ...